FIELD: medicine, narcology. SUBSTANCE: invention proposes new agent for arresting an abstinent syndrome at opiomania. This agent is the known protease inhibitor - aprotinin (or contrycal, trasylol, antagosan, iniprol, gordox). Aprotinin is used in low effective doses, its toxicity is insignificant and therefore it has broad using in narcological practice. EFFECT: enhanced effectiveness of an agent. 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR ABSTINENT SYNDROME ARRESTING AT OPIOMANIA | 1993 |
|
RU2083204C1 |
| PREPARATION FOR TREATING OPIUM NARCOMANIA | 2001 |
|
RU2201761C1 |
| ANALGETIC PREPARATION | 1992 |
|
RU2077326C1 |
| MEDICAL PREPARATION FOR TREATING NARCOMANIA | 1999 |
|
RU2159615C1 |
| MEDICATION FOR WITHDRAWAL SYNDROME MANAGEMENT IN OPIATE DEPENDENCE | 2012 |
|
RU2485954C1 |
| IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
| COMPOSITION FOR TERMINATION OF OPIATE ABSTINENT SYNDROME MANIFESTATIONS | 2007 |
|
RU2323725C1 |
| MEANS FOR OPIOID ABSTINENCE SYNDROME ARRESTING | 2017 |
|
RU2643588C1 |
| ANALGETIC PREPARATION | 1992 |
|
RU2083202C1 |
| DIMERIC DIPEPTIDE MIMETIC BDNF AS AGENT FOR TREATING AND PREVENTING OPIOID ADDICTION | 2023 |
|
RU2823374C1 |
